Hyundai Pharm Co., Ltd.
Records under this name other than the patents Hyundai Pharm Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 3 of 3 · Back to Hyundai Pharm Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,073,830 | Compound for inhibiting 11β-hydroxy steroid dehydrogenase 1, and a pharmaceutical composition comprising the same Lapsed on the fee record Ended Jul 7, 2023 · USPTO record | Lapsed on the fee record | Ended Jul 7, 2023 | USPTO record |
| US 10,292,955 | Composition for external use preparation with improved transdermal permeability Lapsed on the fee record Ended May 21, 2023 · USPTO record | Lapsed on the fee record | Ended May 21, 2023 | USPTO record |
| US 9,758,527 | Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient Lapsed on the fee record Ended Sep 12, 2021 · USPTO record | Lapsed on the fee record | Ended Sep 12, 2021 | USPTO record |